Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Feb 27, 2009 MAIN DOCUMENT DESCRIPTION
4 Feb 27, 2009 MAIN DOCUMENT DESCRIPTION
8-K Feb 26, 2009 FORM 8-K
8-K Feb 13, 2009 FORM 8-K
CORRESP Feb 5, 2009
CORRESP Dec 23, 2008
EFFECT Dec 22, 2008
EFFECT Dec 22, 2008
POS AM Dec 19, 2008 POS AM: POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3
POS AM Dec 19, 2008 POS AM
8-K Dec 19, 2008 FORM 8-K
8-K Dec 2, 2008 FORM 8-K
10-Q Nov 10, 2008 FORM 10-Q
SC 13D Oct 29, 2008
8-K Oct 28, 2008 FORM 8-K
CORRESP Oct 16, 2008
4 Oct 14, 2008 MAIN DOCUMENT DESCRIPTION
DEF 14A Oct 3, 2008 DEFINITIVE PROXY STATEMENT
UPLOAD Oct 2, 2008
8-K Sep 22, 2008 FORM 8-K
4 Sep 8, 2008 MAIN DOCUMENT DESCRIPTION
3 Sep 8, 2008 MAIN DOCUMENT DESCRIPTION
8-K Sep 8, 2008 FORM 8-K
10-Q Aug 8, 2008 FORM 10-Q
8-K Aug 1, 2008 FORM 8-K
← Newer Page 31 of 38 · 935 filings Older →